Published September 6, 2026
Psychopharmacology for Counselors on the NCMHCE: Classes, Side Effects, Emergencies, and Scope
By David Zimmerman · 9 min read · Clinical content
Counselors do not prescribe, and the NCMHCE does not ask you to. It asks you to recognize common medications and their side effects, to know which findings are emergencies, to educate clients accurately, to monitor adherence and safety, and to coordinate with prescribers within scope. This post covers the classes at that depth, drawing on NIMH[1] and the standard therapist handbook[2], with seven scenarios.
The counselor’s role, in one table
| Do | Do not |
|---|---|
| Recognize side effects and document objectively | Recommend starting, stopping, or changing a dose |
| Provide accurate psychoeducation (onset, common effects, what to report) | Attribute side effects to a worsening diagnosis without prescriber input |
| Monitor adherence, mood, and safety (especially early in treatment and after changes) | Contact a prescriber without the client's authorization absent an emergency |
| Encourage the client to communicate with the prescriber; obtain releases; coordinate | Diagnose medical conditions or interpret labs |
| Recognize emergencies (toxicity, serotonin syndrome, NMS, overdose) and route to urgent care | Promise a medication will or will not work |
Classes, examples, and what to watch
| Class | Examples | Used for | Side effects and cautions counselors monitor |
|---|---|---|---|
| SSRIs | Fluoxetine, sertraline, escitalopram, paroxetine | Depression, anxiety, OCD, PTSD, bulimia | GI upset, sexual dysfunction, emotional blunting, weight change, activation; 4–6 weeks to full effect; discontinuation syndrome; black-box warning under 25; serotonin syndrome with other serotonergic agents |
| SNRIs | Venlafaxine, duloxetine | Depression, anxiety, pain | Similar to SSRIs; blood pressure (venlafaxine); discontinuation symptoms |
| Other antidepressants | Bupropion (no sexual side effects; seizure risk; avoid in eating disorders), mirtazapine (sedation, weight gain), trazodone (sleep) | Depression, smoking cessation, sleep | Class-specific as noted |
| TCAs and MAOIs | Amitriptyline, nortriptyline; phenelzine | Depression (second line), pain, migraine | TCAs: lethal in overdose, anticholinergic; MAOIs: hypertensive crisis with tyramine foods and many drugs |
| Mood stabilizers | Lithium; valproate; lamotrigine; carbamazepine | Bipolar disorder | Lithium: narrow window, toxicity (tremor, GI, confusion, ataxia), kidney and thyroid monitoring, dehydration risk; valproate: weight, liver, teratogenic; lamotrigine: rash (Stevens-Johnson) requires immediate care; carbamazepine: blood counts |
| Antipsychotics | First generation (haloperidol); second generation (risperidone, olanzapine, quetiapine, aripiprazole, clozapine) | Schizophrenia, bipolar, augmentation | Extrapyramidal symptoms, akathisia, tardive dyskinesia, metabolic syndrome (weight, glucose, lipids), sedation; NMS (fever, rigidity: emergency); clozapine requires blood monitoring |
| Anxiolytics and hypnotics | Benzodiazepines (alprazolam, lorazepam, clonazepam); buspirone; zolpidem | Acute anxiety, panic, insomnia | Benzodiazepines: tolerance, dependence, cognitive effects, dangerous withdrawal, lethal with opioids/alcohol; buspirone: non-addictive, slow onset |
| Stimulants and non-stimulants | Methylphenidate, amphetamines; atomoxetine, guanfacine | ADHD | Appetite, sleep, heart rate, misuse/diversion; non-stimulants for substance-use history |
| Medications for substance use disorders | Buprenorphine, methadone, naltrexone; acamprosate, disulfiram; naloxone (rescue) | Opioid and alcohol use disorders; overdose reversal | Coordination and psychoeducation; naloxone access for anyone using opioids |
Emergencies to recognize
- Serotonin syndrome: agitation, sweating, tremor, tachycardia, hyperthermia, diarrhea after serotonergic combinations.
- Neuroleptic malignant syndrome: fever, rigidity, autonomic instability, confusion on antipsychotics.
- Lithium toxicity: coarse tremor, vomiting, diarrhea, confusion, ataxia, especially with dehydration or NSAIDs.
- Lamotrigine rash, clozapine fever/sore throat (agranulocytosis), opioid overdose (naloxone), benzodiazepine or alcohol withdrawal (seizures).
- Emerging suicidality early in antidepressant treatment, especially under 25.
The scope sentence
Medication scope is a free Domain 5 drill
The SSRI side-effect drill walks through exactly this reasoning across five questions. 18 free drills, no card.
Scenarios
Interactive
Psychopharmacology for counselors on the NCMHCE
A client on lithium reports coarse tremor, vomiting, diarrhea, confusion, and unsteady gait after a week of a stomach flu. The counselor should:
Related
- Domain 5 practice questions (the SSRI drill).
- Substance use for MOUD and withdrawal.
- Mood differentials for the bipolar/antidepressant switch risk.
Sources
- National Institute of Mental Health — Mental health medications
- Preston, J. D., O'Neal, J. H., Talaga, M. C., & Moore, B. A. (2021). Handbook of Clinical Psychopharmacology for Therapists (9th ed.). New Harbinger.
- SAMHSA — Medications for Substance Use Disorders
Frequently asked questions
Can a counselor tell a client to stop or change a medication?
No. Counselors recognize and document side effects, educate, monitor adherence and safety, and coordinate with the prescriber with the client's authorization. Dose decisions belong to the prescriber; emergencies go to urgent care.
What are the signs of lithium toxicity?
Coarse tremor, vomiting and diarrhea, confusion, slurred speech, and unsteady gait, often after dehydration or new medications such as NSAIDs. It requires urgent medical evaluation.
Ready to practice?
Start drilling NCMHCE-style questions for free — no credit card required.
Start Free Practice →